Bariatric surgery ‘slashes cardiac risk’ in patients with obesity and T2DM

A study shows the treatment is associated with reduced risks of new atherosclerotic disease and mortality

Patients with obesity and type 2 diabetes who undergo bariatric surgery can almost halve their risk of atherosclerotic cardiovascular disease (ASCVD) and reduce their risk of premature death, a study has shown.

The findings should prompt greater awareness of the potential benefits of surgical treatment in weight management, the UK researchers say.